Detection of serum and intrahepatic hepatocyte growth factor in hepatocellular carcinoma.

被引：0
|
作者：
Komine, F
Moriyama, M
Hayashi, N
Suzuki, K
Tanaka, N
Ohkubo, H
Ishizuka, H
Arakawa, Y
Sugitani, M
Uchida, T
机构：
[1] NIHON UNIV, SCH MED, DEPT PATHOL 1, TOKYO, JAPAN
[2] NIHON UNIV, SCH MED, DEPT INTERNAL MED 3, TOKYO, JAPAN
来源：
GASTROENTEROLOGY | 1996年 / 110卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：A1239 / A1239
页数：1
相关论文
共 50 条
  • [31] Des-γ-carboxy prothrombin is a potential autologous growth factor for hepatocellular carcinoma.
    Fujikawa, T
    Suzuki, M
    Shiraha, H
    Takaoka, N
    Ueda, N
    Nakanishi, Y
    Koike, K
    Takaki, A
    Shiratori, Y
    HEPATOLOGY, 2004, 40 (04) : 602A - 603A
  • [32] Expression of vascular endothelial growth factor and its receptors in primary hepatocellular carcinoma.
    Malizia, G
    Rizzo, A
    Aragona, E
    Dino, O
    Albanese, M
    Simonetti, RG
    Virdone, R
    Pisa, R
    Pagliaro, L
    HEPATOLOGY, 1998, 28 (04) : 497A - 497A
  • [33] LOCALIZATION OF HEPATOCYTE GROWTH-FACTOR IN MACROREGENERATIVE NODULES AND HEPATOCELLULAR-CARCINOMA
    THEISE, ND
    YANG, CP
    HYTIROGLOU, P
    FERRELL, L
    JIRTLE, RL
    THUNG, SN
    GERBER, MA
    HEPATOLOGY, 1993, 18 (04) : A194 - A194
  • [34] Inhibitory effect of hepatocyte growth factor on metastasis of hepatocellular carcinoma in transgenic mice
    Shiota, G
    Kawasaki, H
    Nakamura, T
    Schmidt, EV
    RESEARCH COMMUNICATIONS IN MOLECULAR PATHOLOGY AND PHARMACOLOGY, 1996, 91 (01) : 33 - 39
  • [35] Tissue hepatocyte growth factor and proliferating cell nuclear antigen in hepatocellular carcinoma
    Huang, GT
    Lee, HS
    Chen, CH
    Chiou, LL
    Lee, CZ
    Chen, DS
    Hsu, HC
    Sheu, JC
    JOURNAL OF THE FORMOSAN MEDICAL ASSOCIATION, 1999, 98 (02) : 92 - 96
  • [36] Clinical analysis on eight cases of intrahepatic arteriovenous fistula in hepatocellular carcinoma.
    李玉亮
    刘斌
    邵广瑞
    闫明
    张万明
    王永正
    中华肝脏病杂志, 2004, (11) : 45 - 45
  • [37] Vascular endothelial growth factor vascular permeability factor in ascites from patients with hepatocellular carcinoma.
    Minata, M
    Fukuda, Y
    Nishimura, T
    Katsuma, H
    Inoue, M
    Azechi, H
    Matsuoka, Y
    Komeda, T
    Nishida, N
    Ikemoto, M
    Nakao, K
    HEPATOLOGY, 1997, 26 (04) : 1736 - 1736
  • [38] Prognostic Impact of Surgical Complications and Preoperative Serum Hepatocyte Growth Factor in Hepatocellular Carcinoma Patients After Initial Hepatectomy
    Toru Mizuguchi
    Minoru Nagayama
    Makoto Meguro
    Toshihito Shibata
    Shinsuke Kaji
    Takayuki Nobuoka
    Yasutoshi Kimura
    Tomohisa Furuhata
    Koichi Hirata
    Journal of Gastrointestinal Surgery, 2009, 13
  • [39] Prognostic Impact of Surgical Complications and Preoperative Serum Hepatocyte Growth Factor in Hepatocellular Carcinoma Patients After Initial Hepatectomy
    Mizuguchi, Toru
    Nagayama, Minoru
    Meguro, Makoto
    Shibata, Toshihito
    Kaji, Shinsuke
    Nobuoka, Takayuki
    Kimura, Yasutoshi
    Furuhata, Tomohisa
    Hirata, Koichi
    JOURNAL OF GASTROINTESTINAL SURGERY, 2009, 13 (02) : 325 - 333
  • [40] Serum transforming growth factor α in liver cirrhosis and hepatocellular carcinoma
    Zahra, MK
    Badawy, TS
    Ismail, SA
    El-Shazly, SF
    PEDIATRIC RESEARCH, 1999, 45 (05) : 775 - 775
12345